Blastocyst Culture for gender selection
The Institute proposes “Blastocyst culture” for infertile patient. Blastocyst culture is the most advance infertility treatment which involves in vitro fertilization and embryo culture for 5 to 6 days until it reaches the blastocyst stage – a final stage of embryo that is ready to implant in to the uterine wall and become pregnancy.
The best embryo are selected and transfer into the uterine cavity after thay have been analysed for any chromosome abnormalities (Preimplantation genetic diagnosis: PGD) to ensure of having normal chromosome baby (Chromosome 13,18,21, XY) before implanting it into the uterus. Also, gender selection of girl embryo eliminates threat of hemophilia in newborn babies.
How Does PGD Work?
PGD is a therapeutic and genetic testing tool that allows for the analysis and identification of abnormal embryos in individuals at high risk for genetic disorders; and subsequent transfer of healthy embryos back to the uterus. Hemophilia is one of a host of disorders identified through use of the chromosomal genetic testing technique, in addition to more common conditions such as Down Syndrome. The straightforward process involves the following steps:
1) 8-10 cell that are biopsied from blastocyst are used for DNA testing
2) In a laboratory, the testing reveals the sex of the embryo
3) The embryo is also tested to determine its chromosomal makeup
4) Results are obtained within 24-48 hours after biopsy
5) Embryos found to be free of abnormality are transferred